U.S. Court of Appeals for the Federal Circuit
Nalpropion Pharmaceuticals v. Actavis Laboratories Fl, Inc.
This writing
- Type
- Opinion
- Filed
- Aug. 15, 2019
- Case
- Nalpropion Pharmaceuticals v. Actavis Laboratories Fl, Inc.
- Case status
- Decided
Source No authoring judge could be established for this writing, either from provider metadata or from the signature line of the court's published opinion. Benchlight shows the gap rather than guessing at an author.
Opening text
The first passage of the document, as extracted by the source provider.
Opinion dissenting in part filed by Chief Judge Prost. Lourie, Circuit Judge. *1346 Actavis Laboratories FL, Inc. ("Actavis") appeals from the judgment of the U.S. District Court for the District of Delaware that (1) its proposed naltrexone hydrochloride and bupropio…
Source Extract supplied by CourtListener. Benchlight does not host the document — read the authoritative text in the court's own PDF.